Immune Modulation of Autoimmunity by Herbal Products
Immune Modulation of Autoimmunity by Herbal Products
批准号:
8290064
负责人:
KAMAL D MOUDGIL
金额:
$36.75万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-01 至 2016-07-31
关键词:
AddressAdoptedAdoptive TransferAdultAdverse reactionsAffectAmericanAnti-Inflammatory AgentsAnti-inflammatoryAntibodiesAntibody FormationAntibody SuppressionAntigensAntioxidantsArthritisAutoimmune DiseasesAutoimmune ResponsesAutoimmunityBotanicalsCelastraceaeCelastrusCell Migration Inhibition functionCellsCenters for Disease Control and Prevention (U.S.)ChinaChinese HerbsChronicClinicalCommunitiesComplementary and alternative medicineConsumptionDiabetes MellitusDiseaseDisease OutcomeDown-RegulationDrug usageEnhancing AntibodiesExperimental ModelsFamilyFolk RemedyFrequenciesGastrointestinal DiseasesGenerationsHealthcareHeat shock proteinsHerbIL2RA geneImmuneImmune responseImmune systemImmunosuppressive AgentsIn VitroInfiltrationInflammation MediatorsInflammatoryInsulin-Dependent Diabetes MellitusLabelLupusLymphocyteMalignant NeoplasmsMediatingMedicinal HerbsMindModalityModelingMononuclearMultiple SclerosisNational Health Interview SurveyNitric OxideOrganPatientsPatternPharmaceutical PreparationsPlant RootsPlantsProcessProductionPropertyProvincePublishingRattusRegulatory T-LymphocyteRelative (related person)RheumatismRheumatoid ArthritisSerumSeveritiesStrokeSurveysSystemic Lupus ErythematosusT-LymphocyteT-Lymphocyte EpitopesTestingTherapeuticTherapeutic AgentsTherapeutic EffectTissuesToxic effectWaterWestern Worldalternative treatmentbasecostcytokinedesignfeedinghuman NOS2A proteinimmunoregulationin vivomigrationmycobacterialpublic health relevanceresearch studyresponsestemtrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): At least 36 percent of adult Americans adopted some form of complementary and alternative medicine (CAM) therapy for their healthcare needs annually as surveyed 5 years ago (National Interview Health Survey of 2002, CDC). Among CAM modalities, the use of naturally grown plant products as efficacious therapeutic entities as well as the relative lack of toxicity of herbs compared to conventionally used drugs has popularized the consumption of botanical formulas in the western world. Despite the extensive use of medicinal herbs, the mechanisms of action remain unclear for most of them. Our preliminary study using an experimental model of autoimmunity has revealed that the Chinese herb Celastrus suppresses clinical disease and induces significant changes in antigen-specific immune response (e.g., deviation of the cytokine response from pro-inflammatory to anti-inflammatory type, and increased production of antigenspecific antibodies). In this study, we have proposed experiments to test the in-depth mechanisms of Celastrus-induced immune modulation operative via the CD4+CD25+ T regulatory cells (Treg), the in vivo trafficking of lymphocytes into the target organ, the protective antibodies, and the inflammatory mediators. In this respect, our proposal is an excellent match with the objectives of RFA-AT-08-003. Aim 1. To study the suppressive function of CD4+CD25+T cells that leads to the downregulation of the disease process in Celastrus-fed rats. Aim 2. To examine the mechanisms by which Celastrus reduces the migration of potentially pathogenic T cells into the target organ. Aim 3. To determine how enhanced antibody response to the disease-related antigen leads to suppression of the autoimmune response. Aim 4. To test for the Celastrus-induced modulation of inflammatory mediators in the target tissue. Although this proposal involves one CAM modality (a Chinese herb) and one experimental model of autoimmunity, we believe that the basic mechanistic principles elucidated in our study would also be applicable in part to other CAM modalities as well as other models of autoimmunity.
Public Health Relevance: Natural plant products are increasingly being used by patients with a variety of autoimmune diseases, such as diabetes, multiple sclerosis, arthritis and lupus. However, the mechanisms of action of many of these products are not defined. We propose to study the immune system related mechanisms by which Celastrus, a Chinese herb, mediates its beneficial effects against autoimmunity. We will conduct these studies in an experimental model of autoimmunity. The results of our study would help developing rationally designed therapeutic approaches for autoimmunity using botanical products.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Microarray-based gene expression profiling reveals the mediators and pathways involved in the anti-arthritic activity of Celastrus-derived Celastrol.
基于微阵列的基因表达谱分析揭示了与Celastrus衍生的Celastrol抗关节炎活性有关的介体和途径。
DOI:
10.1016/j.intimp.2012.05.015
发表时间:
2012-08
期刊:
International immunopharmacology
影响因子:
5.6
作者:
[Yu H, Venkatesha SH, Moudgil KD]
通讯作者:
Moudgil KD
Temporal cytokine expression and the target organ attributes unravel novel aspects of autoimmune arthritis.
颞细胞因子表达和靶器官属性揭示了自身免疫性关节炎的新方面。
DOI:
--
发表时间:
2013
期刊:
The Indian journal of medical research
影响因子:
--
作者:
[Astry,Brian, Venkatesha,ShivaprasadH, Moudgil,KamalD]
通讯作者:
Moudgil,KamalD
DOI:
10.1155/2013/621417
发表时间:
2013
期刊:
Autoimmune diseases
影响因子:
4
作者:
[Moudgil KD, Thompson SJ, Geraci F, De Paepe B, Shoenfeld Y]
通讯作者:
Shoenfeld Y
DOI:
10.1016/j.bmc.2012.06.050
发表时间:
2012-09-01
期刊:
BIOORGANIC & MEDICINAL CHEMISTRY
影响因子:
3.5
作者:
[Venkatesha, Shivaprasad H., Astry, Brian, Nanjundaiah, Siddaraju M., Yu, Hua, Moudgil, Kamal D.]
通讯作者:
Moudgil, Kamal D.
DOI:
10.1016/j.cellimm.2018.12.005
发表时间:
2019-05
期刊:
Cellular immunology
影响因子:
4.3
作者:
[Langan D, Kim EY, Moudgil KD]
通讯作者:
Moudgil KD
共 13 条
Validation of the joint-homing and drug delivery attributes of novel peptides in a mouse arthritis model
-
批准号:10589192
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Identification of eye-homing peptides and their use for targeted liposomal drug delivery in posterior uveitis
-
批准号:10612913
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2022
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Identification of eye-homing peptides and their use for targeted liposomal drug delivery in posterior uveitis
-
批准号:10452321
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2022
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Anti-arthritic activity and therapeutic use of novel joint-homing peptides
-
批准号:8998611
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Anti-arthritic activity and therapeutic use of novel joint-homing peptides
-
批准号:9339552
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Identification of CNS-homing peptides for therapeutic use in multiple sclerosis
-
批准号:8897016
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2013
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Defining glomerulus-homing peptides for targeted drug delivery in lupus nephritis
-
批准号:8787075
-
项目类别:
-
资助金额:$23.03万
-
财政年份:2013
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Identification of CNS-homing peptides for therapeutic use in multiple sclerosis
-
批准号:8638421
-
项目类别:
-
资助金额:$23.03万
-
财政年份:2013
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Immune Modulation of Autoimmunity by Herbal Products
-
批准号:8103241
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2009
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Immune Modulation of Autoimmunity by Herbal Products
-
批准号:7898955
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2009
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Immune Modulation of Autoimmunity by Herbal Products
-
批准号:7706203
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2009
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Cellular therapy of autoimmunity using antigen-expressing B cells
-
批准号:7532512
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2008
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Cellular therapy of autoimmunity using antigen-expressing B cells
-
批准号:7626023
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2008
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Modulation of Autoimmunity by Green Tea Polyphenols
-
批准号:7140044
-
项目类别:
-
资助金额:$16.17万
-
财政年份:2005
-
负责人:KAMAL D MOUDGIL
-
依托单位:
Modulation of Autoimmunity by Green Tea Polyphenols
-
批准号:6988778
-
项目类别:
-
资助金额:$17.78万
-
财政年份:2005
-
负责人:KAMAL D MOUDGIL
-
依托单位:
REGULATION OF AUTOIMMUNITY THROUGH EPITOPE SPREADING
-
批准号:7020686
-
项目类别:
-
资助金额:$7.25万
-
财政年份:2005
-
负责人:KAMAL D MOUDGIL
-
依托单位:
REGULATION OF AUTOIMMUNITY THROUGH EPITOPE SPREADING
-
批准号:6868054
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2005
-
负责人:KAMAL D MOUDGIL
-
依托单位:
PROFILING SYNOVIAL VASCULATURE IN ARTHRITIS-PRONE RATS
-
批准号:6953243
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2004
-
负责人:KAMAL D MOUDGIL
-
依托单位:
PROFILING SYNOVIAL VASCULATURE IN ARTHRITIS-PRONE RATS
-
批准号:6838430
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2004
-
负责人:KAMAL D MOUDGIL
-
依托单位:
IMMUNOLOGIC BASIS ENIVR MODULATION OF AUTOIM ARTHRITIS
-
批准号:6171234
-
项目类别:
-
资助金额:$14.85万
-
财政年份:1999
-
负责人:KAMAL D MOUDGIL
-
依托单位:
海外基金